Evidence map›Paper›PMID 38073598›Full record

ReviewThe Journal of neuroscience : the official journal of the Society for Neuroscience2023

Resting-State Functional MRI and PET Imaging as Noninvasive Tools to Study (Ab)Normal Neurodevelopment in Humans and Rodents.

Charissa Millevert, Nicholas Vidas-Guscic, Liesbeth Vanherp, Elisabeth Jonckers, Marleen Verhoye, Steven Staelens, Daniele Bertoglio, Sarah Weckhuysen

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. [Brain structure & function · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Charting the path in rodent functional neuroimaging.Imaging neuroscience (Cambridge, Mass.) · 2025
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Charissa MillevertApplied & Translational Neurogenomics Group, Vlaams Instituut voor Biotechnology (VIB) Center for Molecular Neurology, VIB, Antwerp 2610, Belgium.
Nicholas Vidas-GuscicBio-Imaging Lab, University of Antwerp, Antwerp 2610, Belgium.
Liesbeth VanherpµNEURO Research Centre of Excellence, University of Antwerp, Antwerp 2610, Belgium.
Elisabeth JonckersBio-Imaging Lab, University of Antwerp, Antwerp 2610, Belgium.
Marleen VerhoyeBio-Imaging Lab, University of Antwerp, Antwerp 2610, Belgium.
Steven StaelensMolecular Imaging Center Antwerp (MICA), University of Antwerp, Antwerp 2610, Belgium.
Daniele BertoglioBio-Imaging Lab, University of Antwerp, Antwerp 2610, Belgium.
Sarah WeckhuysenApplied & Translational Neurogenomics Group, Vlaams Instituut voor Biotechnology (VIB) Center for Molecular Neurology, VIB, Antwerp 2610, Belgium sarah.weckhuysen@uantwerpen.vib.be.ORCID 0000-0003-2878-1147
University of Antwerp · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurodevelopmental disorders (NDDs) are a group of complex neurologic and psychiatric disorders. Functional and molecular imaging techniques, such as resting-state functional magnetic resonance imaging (rs-fMRI) and positron emission tomography (PET), can be used to measure network activity noninvasively and longitudinally during maturation in both humans and rodent models. Here, we review the current knowledge on rs-fMRI and PET biomarkers in the study of normal and abnormal neurodevelopment, including intellectual disability (ID; with/without epilepsy), autism spectrum disorder (ASD), and attention deficit hyperactivity disorder (ADHD), in humans and rodent models from birth until adulthood, and evaluate the cross-species translational value of the imaging biomarkers. To date, only a few isolated studies have used rs-fMRI or PET to study (abnormal) neurodevelopment in rodents during infancy, the critical period of neurodevelopment. Further work to explore the feasibility of performing functional imaging studies in infant rodent models is essential, as rs-fMRI and PET imaging in transgenic rodent models of NDDs are powerful techniques for studying disease pathogenesis, developing noninvasive preclinical imaging biomarkers of neurodevelopmental dysfunction, and evaluating treatment-response in disease-specific models.

Indexed as

Attention Deficit Disorder with HyperactivityAutism Spectrum DisorderEpilepsyAdultBiomarkersBrainHumansInfantMagnetic Resonance ImagingPositron-Emission TomographyBiomarkersneurodevelopmentneurodevelopmental disorderspositron emission tomographyresting-state functional magnetic resonance imagingrodent models

Identifiers

PMID38073598
PMCPMC10711730
OpenAlexW4389383345

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.